Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 4, 1994 - Issue 4
Submit an article Journal homepage
11
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Overview: Central & Peripheral Nervous System: Recent advances in the discovery and characterization of substance P antagonists

Manoj C Desai Pfiier Inc, Central Research Division, Groton, CT 06340, USA; Chiron Corp, 4560 Horton St, Emeryville, CA, 94608, USA
Pages 315-321 | Published online: 03 Mar 2008

References to Primarv Literaturess

  • CHANG MM, LEEMAN SE, MALL HD: Amino acid sequenceof substance P. Nature (1971)232:86–87.
  • MAGGI CA, PATACCHINI R, ROVERO P, GIACHETTI A:Tachykinin receptors and tachykinin receptor antago-nists J. Auton. Pharmacol. (1993)13:23-93. For a recent review
  • a.NAKANISHI SA: Mammalian tachikinin receptors. Annu. Res. Neurosci. (1991) 14:123–136.
  • b.GERARD NP, BAO L, XIAO-PING H, GERARD C: Molecularaspects of the tachykinin receptors. Regulatory peptides (1993) 43:21-35. For a recent review.
  • a.LEVINE JD, FIELDS HL, BASBAUM Al: Peptides and theprimary afferent nociceptor. J. Neuroscience (1993) 13:2273–2286.
  • b.OTSUKA M, YANAGISAWA M: Pain and neurotransmit-ters. Cell. Molec. Neurobiol. (1990) 10:293–302.
  • CADOR M, RIVET J-M, KELLEY AE, LEMOAL M, STINUS L: Substance P, neurotensins and enkephalin injections Into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res. (1989) 486:357–363.
  • a.MARABINI S, MATUCCI-CERINIC M, GEPPE P, DEL BI-ANCO E, MARCHESONI A, TOSI S, CAGNONI M, PARTSCH G: Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis and psoriatic arthritis synovial fluid. Ann. New York Acad. Sci. (1991) 632:435–436.
  • b.MARCHAND JE, HERSHMAN K, KUMLAR MSA, THOMPSON ML, KREAM RM: Disulfiran2 administration affects sub-stance P-like immunoreactive and monoaminergic neu-ral systems in rodent Brain. J. Biol. Chem (1990) 265:264–273.
  • FROSSARD N, ADVENIER C: Tachykinin receptors and the airways. Life Sci. (1991) 19541–19543.
  • a.SNIDER RM, CONSTANTINE JW, LOWE JA III, LONGO KP,LEBEL WS, WOODY HA, DROZDA SE, DESAI MC, VINICKFJ, SPENCER RW, HESS H-J: A potent nonpeptide antago-nist of the substance P (NKO receptor. Science (1991) 251:435–437.
  • b.McLEAN S, GANONG AH, SEEGER TF, BRYCE DK, PRATT asKG, REYNOLDS LS, SIOK CJ, LOWE JA Ill, HEYM J: Activityand distribution of binding sites in brain of a nonpep-tide substance P (NKO receptor antagonists. Science (1991) 251:437-439. LOWE JA Ill, DROZDA SE, SNIDER RM, LONGO KP, ZORN SF, MORRONE JA, JACKSON ER, MCLEAN S, BRYCE DK, BORDNER J, NAGAHISA A, KANAI Y, SUGA 0, TSUCHIYA M: The discovery of (25, 3S)cis-2-(Diphenylmethyl)-N-[(2-methoxyphenyOmethyl]-1-azabicyclo[2.2.21octan-3-amine as a novel, nonpeptide substance P antagonist. J. Med. Chem. (1992) 35:2591–2600.
  • DESAI MC, LEFKOWITZ SL, THADEIO PF, LONGO KP, asSNIDER RM: Discovery of a potent substance P antago-nist recognition of the key molecular determinant. J. Med. Chem. (1992) 35:4911-4913. LOWE JA III: Substance P antagonists. Drugs of the Future (1992) 17:1115-1121. LOWE JA III, SNIDER RM: Substance P antagonists. Drug News and Perspective (1992) 5:223-228. LOWE JA III, DROZDA SE, SNIDER RM, LONGO KP, RIZZI JP: Nuclear variations of quinuclidine substance P an-tagonists: 2-diphenylmethy1-1-azabicyclo[3.2.21 nonan-3-amines. Bin. Med. Chem. Lett. (1993) 3:921–924.
  • b.LOWE JA 111 Substance P antagonists. Drugs of the Future(1’92) 17:1115–l121.
  • novel tachykinin antagonist from a strepyomyces. Org. Chem. (1993) 58:170–175.
  • GARRET C, CARRUETTE A, FARDIN V, MOUSSAWOUI S, PEYRONEL J-F, BLANCHARD JC, LADURON PM: Pharma-cological properties of a potent and selective nonpep-tide substance P antagonist Proc. Natl. Acad. Sci. USA (1991) 88:10208–10212.
  • PERYNEL J-F, TRUCHON A, MOUTONNLER C, GARRET C: Synthesis of RP-67580, a new potent nonpeptide sub-stance P antagonist. Bin. Med. Chem. Lett. (1992) 2:37–40.
  • VENEPALLI BR, AIMONE LD, APPELL KC, BELL MR, DORITY JA, GOSWAMI R, HALL PL, 'KUMAR V, LAWRENCE KB, LOGAN ME, SCENSNY PM, SEELYE JA, TOMCZUK BE, YANNI JA: Synthesis and substance P receptor binding activity of androstano[3,2-8] pyrimido [1,2-al benzimid-fazoles. J. Med. Chem. (1992) 35:374–378.
  • APPELL KC, BABB BE, GOSWAMI R, HALL PL, LAWRENCEKB, LOGAN ME, PRZY1CLEK ELLING R, TOMCZUK BE, VENEPALLI BR, YANNI JM: Imidazo [4,5-b]quinoxaline cyanines as neurokinin antagonists.' Med. Chem. (1992) 35:1751–1753.
  • LAWRENCE KB, VENPALLI BR, APPELL KC, GOSWAMI R,LOGAN ME, TOMCZUK BE, YANNI JM: Synthesis and substance P antagonist activity of naphthimidazolium derivatives. J. Med. (1992) 36:1273–1279.
  • WONG S-M, MUSZA LL, KYDD GC, KULLNIG R, GILLUMAM, COOPER R: Fiscalins: new substance P inhibitors produced by the fungus neosatotya fiscberi: taxon-omy, fermentation, structures, and biological proper-ties. J. Antibiol. (1993) 46:545–553.
  • SHIGEMATSU N, HAYASHI K, KAYAKIRI N, TAKASE S, HASHIMOTO M, TANAKA H: Structure of WS9326A, a ha.
  • HAYASHI K, HASHIMOTO M, SHIGEMATSU N, NISHIKAWA M, EZAIU M, YAMASHITA M, KIYOTO S, OKUHARA M, KOHSAKA M, IMANAKA H: WS9326A, A novel tachyltinin antagonist isolated from streptomyces violaceusniger No. 9326.1 taxonomy, fermentation, isolation physico-chemical properties and biological activities./ Antibiot. (1992) 45:1055–1063.
  • HASHIMOTO M, HAYASHI K, MURAI M, FUJII T, NISHIKAWA M, KIYOTO S,OKUHARA M, KOHSAKA M, IMANAKA H: WS9326A, a novel tachykinin antagonist isolated from streptomyces violaceusniger No.9326.11 Biological and pharmacological properties of WS9326A and tetrahydro-WS9326A (FK224). j Antibiot. (1992) 45:1064–1070.
  • MIZRAHI J, ESCHER E, D'ORLEANS-JUSTE P, REGOLI D:Undeca- and octa-peptide antagonists for substance P, a study on the guinea-pig trachea. Eur. j Pharmacol. (1984) 99:193–202.
  • HAGIWARA D, MIYAKE H, MORIMOTO H, MLTRAI M, FUJII T, MATSUO M: Studies on neurokinin antagonists. 1. the design of novel tripeptides possessing the glutaminyl-D-tryptophylphenylalanine sequence as substance P antagonists.]. Med. Chem. (1992) 35:2015–2025.
  • MORIMOTO H, MURAI M, MAEDA Y, HAGIWARA D, MI-YAKE H, MATSUO M, FUJII T: FR113680: A novel tripep-tide substance P antagonist with NIQ receptor selectivity. Br. J. Pharmacol. (1992) 106:123–126.
  • HAGIWARA D, MIYAKE H, MORIMOTO H, MURIA M, FUJII T, MATSUO M: Studies on neurokinin antagonists. 2. Design and structure-activity relationships of novel tripeptide substance P antagonists, N "-[N'- (Na-acety1-1,threonyDATI-fortnyl-D-tryptophyl]-N-methyl-N-(ph enylmethyD-L-phenylalaninamicle and its related com-pounds. J. Med. Chem. (1992) 35:3184–3191.
  • FUJII T, MURAI M, MORIMOTO H, MAEDA Y, YAMAOKA M,HAGIWARA D, MIYAKE H, IKARI N, MATSUO M: Phar-macological profile of a high affinity dipeptide NK2 receptor antagonists, FK888. Br.]. Pharmacol. (1992) 107:785–789.
  • WARD P, EWAN GB, JORDAN CC, IRELAND SJ, HAGAN RM, BROWN JR: Potent and highly selective neurokinin Antagonists. J. Med. Chem. (1990) 33:1848–1851.
  • YAJIMA H, KETAGAWA K, SEGAWA T: Studies on pep-tides. XXX'VIII. Stucture-activity correlations in sub-stance P. Chem. Pharm. Bull(1973) 21:2500–2506.
  • WILLIAMS BJ, CURTIS NR, McKNIGHT AT, MAGUIRE JJ,YOUNG SC, VEBER DF, BAKER R: Cyclic peptides as selective tachykinin antagonists. J. Med. Chem. (1993) 36:2–10.
  • SEWARD EM, SWAIN CJ, MERCHANT KJ, OWEN SN, SABIN V, CASCIERI MA, SADOWSAKI S, STRADER C, BAKER R: Quinuclidine-based NICt antagonists I: 3-Benzyloxy-1-azabicyclo[2.2.2]octanes. Bio. Med. Chem. Lett. (1993) 3:1361–1366.
  • MacLEOD AM, MERCHANT KJ, CASCIERI MA, SADOWSKI S,BER E, SWAIN CJ, BAKER R: N-Acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists.]. Med. Chem (1993) 36:2044–2045.
  • EMONDS-ALT X, VILAIN P, GOULAOUIC P, PROIEITO V,VAN BROECK D, ADVENIER C, NALINE E, NELIAT G, LE FUR G, BRELIERE JC: A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor. Life Sci. (1992) 50:PL-101-PL–106.
  • HIRSCHMANN R, NICOLAOU KC, PIETRANICO S, SALVINOJ, LEAHY EM, SPRENGELER PA, FURST G, SMITH AB III, STRADER CD, CASCIERI MA, CANDELORE MR, DONALD-SON C, VALE W, MAECHLER L: Nonpeptidal pepti-domimetics with a P-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relation-ship to a potent, selective substance P antagonist.]. Am. Chem. Soc (1992) 114:9217–9218.

References to patent literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.